References for "Quality of care indicators for the management of Staphylococcus aureus bacteraemia (SAB) in adults"

Al-Hasan MN, Rac H. Transition from intravenous to oral antimicrobial therapy in patients with uncomplicated and complicated bloodstream infections. Clinical Microbiology and Infection. 2020 Mar 1;26(3):299-306.

Arensman K, Dela-Pena J, Miller JL, LaChance E, Beganovic M, Anderson M, Rivelli A, Wieczorkiewicz SM. Impact of mandatory infectious diseases consultation and real-time antimicrobial stewardship pharmacist intervention on Staphylococcus aureus bacteremia bundle adherence. Open forum infectious diseases 2020 Jun 7;(6): p. ofaa184.

Bai AD, Morris AM. Management of Staphylococcus aureus bacteremia in adults. CMAJ. 2019 Sep 3;191(35):E967. 

Dagher M, Fowler Jr VG, Wright PW, Staub MB. A narrative review of early oral stepdown therapy for the treatment of uncomplicated Staphylococcus aureus bacteremia: yay or nay? Open forum infectious diseases 2020 Jun 7;(6): p. ofaa151.

Holland TL. Early oral antibiotic switch for Staphylococcus aureus bacteremia: many are called, but few are chosen. Antimicrobial Agents and Chemotherapy. 2020 Jun 23;64(7):e00317-20.

Kimmig A, Hagel S, Weis S, Bahrs C, Löffler B, Pletz MW. Management of Staphylococcus aureus bloodstream infections. Frontiers in Medicine. 2021 Mar 5;7:616524.

Kouijzer IJ, van Leerdam EJ, Gompelman M, Tuinte RA, Aarntzen EH, Berrevoets MA, Maat I, Bleeker-Rovers CP, van Crevel R, Ten Oever J. Intravenous to oral switch in complicated Staphylococcus aureus bacteremia without endovascular infection: a retrospective single-center cohort study. Clinical Infectious Diseases. 2021 Sep 1;73(5):895-8.

Kuehl R, Morata L, Boeing C, Subirana I, Seifert H, Rieg S, Kern WV, Kim HB, Kim ES, Liao CH, Tilley R. Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study. The Lancet infectious diseases. 2020 Dec 1;20(12):1409-17.

López-Cortés LE, Del Toro MD, Gálvez-Acebal J, Bereciartua-Bastarrica E, Fariñas MC, Sanz-Franco M, Natera C, Corzo JE, Lomas JM, Pasquau J, Del Arco A. Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia. Clinical Infectious Diseases. 2013 Nov 1;57(9):1225-33.

Pérez-Rodríguez MT, Sousa A, Moreno-Flores A, Longueira R, Diéguez P, Suárez M, Lima O, Vasallo FJ, Álvarez-Fernández M, Crespo M. The benefits and safety of oral sequential antibiotic therapy in non-complicated and complicated Staphylococcus aureus bacteremia. International Journal of Infectious Diseases. 2021 Jan 1;102:554-60.

Ten Oever J, Jansen JL, van der Vaart TW, Schouten JA, Hulscher ME, Verbon A. Development of quality indicators for the management of Staphylococcus aureus bacteraemia. Journal of Antimicrobial Chemotherapy. 2019 Nov 1;74(11):3344-51.

Willekens R, Puig-Asensio M, Suanzes P, Fernández-Hidalgo N, Larrosa MN, González-López JJ, Rodríguez-Pardo D, Pigrau C, Almirante B. Mortality in Staphylococcus aureus bacteraemia remains high despite adherence to quality indicators: secondary analysis of a prospective cohort study. Journal of Infection. 2021 Dec 1;83(6):656-63.